HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gabaglia, C. R. Articles by Braciak, T. A. Search for Related Content PubMed PubMed Citation Articles by Gabaglia, C. R. Articles by Braciak, T. A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Leishmaniasis

A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice¹

Claudia Raja Gabaglia^2,*, Brian Pedersen^*, Mary Hitt, Nicolas Burdin, Eli E. Sercarz^*, Frank L. Graham, Jack Gauldie and Todd A. Braciak^*

^* Division of Immune Regulation and Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121; and Department of Pathology, McMaster University, Hamilton, Ontario, Canada

Experimental infection of the susceptible BALB/c (H-2^d) mouse with the intracellular parasite Leishmania major induces a predominant Th2-type T cell response that eventually leads to death. In contrast, the resistant B10.D2 (H-2^d) strain develops Th1 cells that control parasite replication and disease. In this study, we tested the ability of a recombinant adenovirus vector-expressing IL-12 to skew the immune response in a Th1 direction and prevent leishmaniasis in susceptible mice. We report that BALB/c mice treated with the Ad5IL-12 vector on the same day as parasitic challenge are significantly protected against leishmaniasis and acquired long-lasting immunity, because upon rechallenge with L. major parasites they were resistant to disease. The vector-derived IL-12 expression was transient and highly localized to the tissue after i.m. injection; it caused an increase in the number of Ag-specific IFN--secreting lymphocytes and enhanced NK cell activity in the draining popliteal node. In contrast, resistant B10.D2 mice given i.m. injections with a recombinant adenovirus-expressing IL-4 displayed greater susceptibility to disease, and severe lesions were produced in some of the infected animals. These results suggest the potential use of recombinant adenoviruses expressing cytokines as potent immunomodulatory agents for the generation of protective immune responses against intracellular pathogens.

This article has been cited by other articles:

				C. Raja Gabaglia, Y. Diaz de Durana, F. L. Graham, J. Gauldie, E. E. Sercarz, and T. A. Braciak Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell-Mediated Killing of MHC Class I-Negative LNCaP Prostate Tumors Cancer Res., March 1, 2007; 67(5): 2290 - 2297. [Abstract] [Full Text] [PDF]

				Y. Diaz-de-Durana, G. T. Mantchev, R. J. Bram, and A. Franco TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo Blood, January 15, 2006; 107(2): 594 - 601. [Abstract] [Full Text] [PDF]

				T. A. Braciak, B. Pedersen, J. Chin, C. Hsiao, E. S. Ward, I. Maricic, A. Jahng, F. L. Graham, J. Gauldie, E. E. Sercarz, et al. Protection Against Experimental Autoimmune Encephalomyelitis Generated by a Recombinant Adenovirus Vector Expressing the V{beta}8.2 TCR Is Disrupted by Coadministration with Vectors Expressing Either IL-4 or -10 J. Immunol., January 15, 2003; 170(2): 765 - 774. [Abstract] [Full Text] [PDF]

				E. F. Verdu, Y. Deng, P. Bercik, and S. M. Collins Modulatory effects of estrogen in two murine models of experimental colitis Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G27 - G36. [Abstract] [Full Text] [PDF]

				H. W. Murray Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis Antimicrob. Agents Chemother., August 1, 2001; 45(8): 2185 - 2197. [Full Text] [PDF]

				W. I. Khan, P. A. Blennerhassett, Y. Deng, J. Gauldie, B. A. Vallance, and S. M. Collins IL-12 gene transfer alters gut physiology and host immunity in nematode-infected mice Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G102 - G110. [Abstract] [Full Text] [PDF]

				H.-W. Chen, C.-H. Pan, H.-W. Huan, M.-Y. Liau, J.-R. Chiang, and M.-H. Tao Suppression of Immune Response and Protective Immunity to a Japanese Encephalitis Virus DNA Vaccine by Coadministration of an IL-12-Expressing Plasmid J. Immunol., June 15, 2001; 166(12): 7419 - 7426. [Abstract] [Full Text] [PDF]

				F. Dieli, G. Sireci, D. Russo, M. Taniguchi, J. Ivanyi, C. Fernandez, M. Troye-Blomberg, G. De Leo, and A. Salerno Resistance of Natural Killer T Cell-deficient Mice to Systemic Shwartzman Reaction J. Exp. Med., December 4, 2000; 192(11): 1645 - 1652. [Abstract] [Full Text] [PDF]

				W. C. Russell Update on adenovirus and its vectors J. Gen. Virol., November 1, 2000; 81(11): 2573 - 2604. [Full Text]

				E. Maverakis, J. T. Beech, S. S. Wilson, A. Quinn, B. Pedersen, and E. E. Sercarz T Cell Receptor Complementarity Determining Region 3 Length Analysis Reveals the Absence of a Characteristic Public T Cell Repertoire in Neonatal Tolerance: The Response in the "Tolerant" Mouse within the Residual Repertoire Is Quantitatively Similar but Qualitatively Different J. Exp. Med., February 21, 2000; 191(4): 695 - 702. [Abstract] [Full Text] [PDF]

				V. Julia and N. Glaichenhaus CD4+ T Cells Which React to the Leishmania major LACK Antigen Rapidly Secrete Interleukin-4 and Are Detrimental to the Host in Resistant B10.D2 Mice Infect. Immun., July 1, 1999; 67(7): 3641 - 3644. [Abstract] [Full Text] [PDF]